Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
[1]
Current assets:    
Cash and cash equivalents $ 17,982,672 $ 13,213,929
Other current assets 104,550 15,711
Total current assets 18,087,222 13,229,640
Other non-current assets 68,858 122,381
Total assets 18,156,080 13,352,021
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 542,068 724,165
Current portion of bank loan 67,772 0
Total current liabilities 609,840 724,165
Long-term liabilities:    
Non-current portion of bank loan 54,628 0
Total long-term liabilities 54,628 0
Total liabilities 664,468 724,165
Commitments and contingencies (Note 6)
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 authorized, 11,452,177 and 10,587,632 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 11,452 10,587
Additional paid-in capital 47,546,915 38,508,825
Accumulated other comprehensive loss (10,044) (10,970)
Accumulated deficit (30,056,711) (25,880,586)
Total stockholders' equity 17,491,612 12,627,856
Total liabilities and stockholders' equity $ 18,156,080 $ 13,352,021
[1] Derived from the Company's audited consolidated financial statements.